GlaxoSmithKline
GSK
#208
Rank
$98.04 B
Marketcap
$48.57
Share price
-0.82%
Change (1 day)
45.99%
Change (1 year)

Earnings for GlaxoSmithKline (GSK)

Earnings in 2025 (TTM): $9.32 Billion USD

According to GlaxoSmithKline's latest financial reports the company's current earnings are $42.35 Billion USD. In 2024 the company made an earning of $4.39 Billion USD a decrease over its 2023 earnings that were of $7.54 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for GlaxoSmithKline from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $9.32 B112.1%
2024 $4.39 B-41.77%
2023 $7.54 B8.82%
2022 $6.93 B13.13%
2021 $6.13 B-30.54%
2020 $8.82 B11.27%
2019 $7.93 B25.27%
2018 $6.33 B37.6%
2017 $4.60 B80.19%
2016 $2.55 B-83.68%
2015 $15.64 B218.89%
2014 $4.90 B-53.58%
2013 $10.57 B-0.23%
2012 $10.59 B-13.02%
2011 $12.18 B148.67%
2010 $4.89 B-60.78%
2009 $12.48 B2.26%
2008 $12.21 B-18.89%
2007 $15.05 B4.96%
2006 $14.34 B19.41%
2005 $12.01 B5.31%
2004 $11.40 B8.79%
2003 $10.48 B24.69%
2002 $8.40 B-3.91%
2001 $8.75 B-3.96%
2000 $9.11 B261.88%
1999 $2.51 B-5.55%
1998 $2.66 B-42.55%
1997 $4.63 B-37.42%
1996 $7.41 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
$13.09 B 40.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$11.85 B 27.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B 147.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B 76.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$9.10 B-2.39%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
$1.77 B-80.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
-$33.89 Million-100.36%๐Ÿ‡บ๐Ÿ‡ธ USA